Molecular Templates

$8.84
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.66 (-6.95%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell MTEM and other stocks, options, and ETFs commission-free!

About MTEM

Molecular Templates, Inc. Common Stock, also called Molecular Templates, is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. Read More The company utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. Molecular Templates was founded by Eric E. Poma, Jean Gariépy and Leigh Revers on October 17, 2001 and is headquartered in Austin, TX. The listed name for MTEM is Molecular Templates, Inc. Common Stock.

CEO
Eric E. Poma
Employees
168
Headquarters
Austin, Texas
Founded
2000
Market Cap
441.29M
Price-Earnings Ratio
Dividend Yield
Average Volume
251.04K
High Today
$9.50
Low Today
$8.70
Open Price
$9.50
Volume
271.76K
52 Week High
$19.12
52 Week Low
$6.80

Collections

MTEM Earnings

-$0.68
-$0.45
-$0.23
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 5, After Hours

You May Also Like